Anavex (AVXL) blarcamesine faces uncertain FDA path in early Alzheimer’s; Phase 3 may be needed. Read here a detailed ...
Public Citizen asked the FDA to ban high-dose Aricept because of side effects. May 19, 2011— -- Public Citizen has petitioned the Food and Drug Administration to ban high doses of the Alzheimer's ...
July 27, 2010 — The US Food and Drug Administration (FDA) has approved donepezil HCl 23-mg tablets (Aricept; Eisai, Inc and Pfizer, Inc) for the once-daily treatment of moderate to severe Alzheimer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results